National Trial Lawyers
Our lawyers exclusively represent plaintiffs, typically consumers and their families, on a contingent fee basis meaning that we advance all costs for your case and we are compensated for our respresentation only if we are successful for you. You stand to recover money—never lose money—by pursuing a case with us.
In 2010 alone, Chaffin Luhana recovered nearly $100 million for its clients in product liability cases. The results we have achieved are the product of our skill, experience and hard work— all of which have drawn national attention from prominent media shows such as ABC WorldNews with Diane Sawyer, Good Morning America and The Today Show.
Chaffin Luhana also prides itself in giving back to the communities that have trusted the firm with protecting its people. The Chaffin Luhana Foundation makes generous gifts to important public causes. The Foundation is a philanthropic reflection of the firm's stated mission of Doing Good by Doing Right.
Read our Client Testimonials.
We Focus On Your Legal Case So You Can Focus on Your Recovery
You and your family have suffered enough. We will focus on your legal case so you and your family can focus on your healing and recovery. Our firm is different from our competition because of our breadth of experience, our recoveries for our clients and our unique perspective.
We have the necessary experience, staff and ability to cut through legal, factual and medical issues quickly so that we can focus on the key issues in your case, thereby saving you time and energy.
Call Us Toll Free at 1-888-480-1123
The most difficult news we sometimes must deliver to prospective clients is that they waited too long to contact us. Every state has a unique statute of limitations that bars victims from bringing legal actions after a legally specified period of time. Once the statute of limitations expires, there is nothing we can do to get your family the compensation it deserves. We are a simple phone call or email away. Call us at 1-888-480-1123 before it is too late.
By submitting this form you acknowledge that doing so does not create an attorney client relationship and authorizes submitted information to be shared with co-counsel.
Privacy protected.
All information held in confidence.
CONSUMER CASE SPOTLIGHT
FDA Warns of Complications with Vaginal Mesh
The FDA has released a second warning on vaginal mesh, this time stating that serious complications with the surgery are not rare. The agency first alerted the public and healthcare professionals to the concern in October 2008, after they had received over 1,000 reports of problems with different types of mesh. Then, between 2008 and 2010, they received five times as many reports as they had between 2005 and 2007. Studies confirmed what the reports were saying, leading the FDA to release its July 2011 warning stating that surgical repair of pelvic organ prolapse with mesh may be no better than conventional surgeries without it, and may cause lasting damage. Meanwhile, many women have come forward with vaginal mesh lawsuits claiming injuries like bleeding, infection, urinary problems, erosion, and migration of the mesh. Several brands of mesh made by C. R. Bard are named in Bard Avaulta mesh lawsuits, with women claiming Bard Avaulta mesh side effects like severe pain in the pelvic area, back, hips, or legs, as well as organ perforation and chronic infections. Bard Avaulta lawyers assert that the mesh is defectively designed, and are seeking Avaulta mesh settlements to help their plaintiffs pay for medical expenses, pain and suffering. For a review of your potential Bard Avaulta mesh lawsuit, contact us by completing the form on this page or calling 1-888-480-1123.
Actos Bladder Cancer Lawsuits to be Consolidated?
Numerous plaintiffs claiming Actos bladder cancer have petitioned the U. S. Judicial Panel on Multidistrict Litigation to consolidate the cases before a single judge. Since August 2011, the number of Actos lawsuits has steadily increased as more patients become aware of the serious health risks associated with the diabetes drug. For years, studies have indicated a link between Actos and bladder cancer, with a 2005 clinical trial showing that those taking Actos were more likely to be diagnosed with bladder cancer than those treated with other drugs. The FDA finally commenced its own investigation in 2010. In the spring of 2011, after reviewing data from the manufacturer's post-marketing study, they found that those taking Actos for more than a year had a 40 percent greater risk of Actos bladder cancer. Meanwhile, on June 9, the French Medicines Agency implemented an Actos recall, citing data from the French National Health Insurance Plan indicating a risk of Actos bladder cancer. On June 15, 2011, the FDA released a public health warning and required a label change concerning Actos side effects. In August, the first of many Actos lawsuits claiming Actos bladder cancer was filed. The U.S. Judicial Panel on Multidistrict Litigation is expected to meet in December to consider the petition to consolidate. For a review of your potential Actos lawsuit, contact us by completing the form on this page or calling 1-888-480-1123.
Denture Cream Lawsuits
Various studies have linked excessive intake of zinc from the popular Super Poligrip and Fixodent denture adhesives to copper deficiency, blood disorders and nerve damage. ABC WorldNews with Diane Sawyer recently profiled Chaffin Luhana LLP client Mark Jacoby, who the firm is pursuing a denture cream lawsuit for, in a segment about how a dentist from Michigan, Dr. Kenneth Shay, allegedly leaked a copy of a medical journal article to Proctor & Gamble in 2007 before it was published in the Journal of Neurology. The Neurology article was finally published in 2008 and identified a syndrome now referred to as denture cream zinc poisoning and denture cream copper deficiency. Our denture cream lawyers are ready to review your potential denture cream lawsuit. Contact us by completing the form on this page or calling us at 1-888-480-1123.
Yaz, Yasmin & Ocella Lawsuits
Thousands of lawsuits have been filed against the manufacturers of Yasmin/YAZ/Ocella, including Bayer, by plaintiffs alleging that they have suffered pulmonary emboli, deep vein thrombosis, stroke and gallbladder disease as a result of their Yasmin/YAZ/Ocella use. Judge David R. Herndon presides over all the Yasmin/YAZ/Ocella federal lawsuits in the multidistrict litigation (MDL) in the Southern District of Illinois where cases are being coordinated and centralized for pre-trial discovery and proceedings. There are hundreds of cases also pending in state courts in New Jersey, Pennsylvania and California where some of the defendants are based. The litigation is moving rapidly in the MDL where millions of pages have been produced in discovery, numerous depositions have been taken and bellwether trial selection is underway. The first pulmonary embolism trial is set to take place in September 2011 with a deep vein thrombosis and gallbladder disease case set be tried in 2012. The bellwether process will help plaintiffs and defendants determine how juries evaluate and value these type of cases and respective injuries and may dictate the landscape for the other thousands of filed cases.
Depuy Hip Lawsuits
Depuy, a Johnson & Johnson company, recalled its ASR hip replacement systems because its componets can loosen, fracturing the bone around the implant. As a result of the defect, metal can be deposited in the patient's bloodstream causing non-cancerous tumors. While, ASR Hips that are meant to last approximately fifteen (15) years they can fail because of this defect within only a few years of surgery, requiring revision surgery. Our Depuy Hip lawyers are investigating recalled DePuy ASR hip replacement systems and filing DePuy Hip Replacement lawsuits on behalf of injured consumers.
New Fosamax Study Further Links Bisphophosphonates to Femur Fractures
In 2010, the FDA warned the medical community about a possible risk of atypical thigh bone (femoral) facture in patients who take bisphophosphonates such as Fosamax, Didronel, Boniva, and Actonel. Since then, a number of Fosamax femur fracture lawsuits have been filed in federal and state courts. More recently, on February 23, 2011, the Journal of the American Medical Association (JAMA) published "Bisphosphonate Use and the Risk of Sutrochanteric or Femoral Shaft Fractures in Older Women" authored by Laura Park-Whillie, et al. The authors concluded, among other things, that "[a]mong older women, treatment with a bisphosphonate for more than 5 years associated with an increased risk of subtrochanteric or femoral shaft fractures[.]" Femoral (thigh bone) fractures, particularly femoral neck fractures, which are those that occur in the neck of the femur that joins the femur to the hip socket, have proven to be serious injuries that are associated with high mortality (death) and significant morbidity in the geriatric population.
